INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![oncology-GettyImages-2191794159]( "How To Accelerate Early-Phase Oncology Trial")
How To Accelerate Early-Phase Oncology TrialPurpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.
-
![Panel Discussion]( "Harnessing The Potential Of Patient-Level Data In Clinical Trials")
Harnessing The Potential Of Patient-Level Data In Clinical TrialsJoin our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
-
![GettyImages-1441665189 lab]( "Considerations For Subcutaneous, Intramuscular Formulation Development")
Considerations For Subcutaneous, Intramuscular Formulation DevelopmentExplore the changing landscape of parenteral delivery, considering the pros and cons of intravenous, subcutaneous, and intramuscular formulations, and how new technologies are reshaping drug delivery.
-
![Bioanalysis-CRO-GettyImages-1315366428]( "How A Strategic Bioanalysis CRO Partnership Empowers Sponsors")
How A Strategic Bioanalysis CRO Partnership Empowers SponsorsChoosing the right bioanalysis CRO is vital to avoid costly delays. Sponsors need evaluation strategies that prioritize proven quality, predictable timelines, and submission-ready data.
-
Specialized Site Network For Early-Phase Oncology Success10/2/2025
Early-phase oncology trials are complex, demanding precision, rapid execution, and specialized expertise. Yet, too often, the operational burden falls on clinical sites―already overworked and stretched thin. Within large, volume-driven CRO networks, this creates a system that prioritizes scale over quality, offering minimal site support, delaying timelines, and ultimately compromising trial outcomes.
-
Creating A New World In Clinical Trial Feasibility Utilizing Advanced Analytics11/26/2024
Citeline utilizes several data resources to enhance feasibility strategies and help clients drive patient engagement and recruitment.
-
The Ten Commandments Of Vendor Selection7/1/2025
Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.
-
Central eSource Is The Latest In Sponsor Provided Site Offerings7/7/2025
For decades, sponsors have provided tools to help clinical sites work more efficiently. Central eSource is the latest evolution in this trend.
-
Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials2/24/2026
A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![GettyImages-2036497889-lab-computer-research]( "What Our Portal Does For Sites, Sponsors, And Patients")
Clinical trial portals should reduce friction—not add it. Streamlined tools empower sites, support patients, and give sponsors visibility without micromanagement or unnecessary complexity.
-
![GettyImages-911404660-driving-car-road]( "Remove This Top Barrier And Stop Losing Clinical Trial Participants")
Comprehensive travel and concierge support removes barriers to clinical trial participation, easing burdens for patients and sites while boosting retention and research outcomes.
-
![GettyImages-1467006387 doctor at computer]( "Forecast And Budget Investigator Grants Confidently")
Integrate data from all industry sources to confidently plan budgets for studies worldwide, across all phases and therapeutic areas.
-
![GettyImages-966266114 CRA]( "Rave TSDV - Improve CRA Efficiency And Reduce Site Burden")
Source data verification (SDV) is a critical activity within clinical trial monitoring, yet the traditional approach focused on 100% SDV is limited in its ability to quickly identify issues and prevent them from recurring. Rave TSDV (Targeted SDV), unified with Rave EDC, enables CRAs to focus on critical to quality (CtQ) factors identified within risk management activities.
-
![clinical-sites-GettyImages-2057440780]( "A Premier Site Network For High-Performance Trials")
A national research network with advanced facilities, expert investigators, and diverse patients to support efficient Phase I–IV trials and speed complex protocols and enrollment.
